Abellanosa, Maychel .
HRN: 29-41-53 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/10/2026
CEFUROXIME 500MG (TAB)
08/10/2026
08/17/2026
PO
500
Bid
Ltcs
Checking Initial Appropriateness
Indication: ProphylaxisEmpiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines